ZA861505B - Labdan-derivatives,a process for their preparation and their use as medicaments - Google Patents
Labdan-derivatives,a process for their preparation and their use as medicamentsInfo
- Publication number
- ZA861505B ZA861505B ZA861505A ZA861505A ZA861505B ZA 861505 B ZA861505 B ZA 861505B ZA 861505 A ZA861505 A ZA 861505A ZA 861505 A ZA861505 A ZA 861505A ZA 861505 B ZA861505 B ZA 861505B
- Authority
- ZA
- South Africa
- Prior art keywords
- medicaments
- preparation
- labdan
- derivatives
- labdanes
- Prior art date
Links
- 239000003814 drug Substances 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000004406 elevated intraocular pressure Effects 0.000 abstract 1
- 239000000543 intermediate Substances 0.000 abstract 1
- 229930002697 labdane diterpene Natural products 0.000 abstract 1
- 150000001761 labdane diterpenoid derivatives Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H5/00—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/78—Ring systems having three or more relevant rings
- C07D311/92—Naphthopyrans; Hydrogenated naphthopyrans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/10—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1804—Compounds having Si-O-C linkages
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/655—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
- C07F9/65502—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a three-membered ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Ophthalmology & Optometry (AREA)
- Pulmonology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Steroid Compounds (AREA)
- Management, Administration, Business Operations System, And Electronic Commerce (AREA)
- Lubricants (AREA)
- Ink Jet (AREA)
- Fire-Extinguishing Compositions (AREA)
- Saccharide Compounds (AREA)
- Pyrane Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US70728385A | 1985-03-01 | 1985-03-01 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA861505B true ZA861505B (en) | 1987-06-24 |
Family
ID=24841093
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA861505A ZA861505B (en) | 1985-03-01 | 1986-02-28 | Labdan-derivatives,a process for their preparation and their use as medicaments |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP0193132B1 (ja) |
| JP (1) | JPS61210081A (ja) |
| KR (1) | KR910007967B1 (ja) |
| AT (1) | ATE62683T1 (ja) |
| AU (1) | AU577928B2 (ja) |
| DE (1) | DE3678736D1 (ja) |
| DK (1) | DK92786A (ja) |
| ES (4) | ES8705414A1 (ja) |
| FI (1) | FI860842A (ja) |
| GR (1) | GR860571B (ja) |
| HU (1) | HUT42080A (ja) |
| NO (1) | NO860758L (ja) |
| PH (1) | PH23778A (ja) |
| PT (1) | PT82097B (ja) |
| ZA (1) | ZA861505B (ja) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3581725D1 (de) * | 1984-12-14 | 1991-03-14 | Hoechst Roussel Pharma | Aminoacyllabdane, verfahren und zwischenprodukte zu ihrer herstellung und ihre verwendung als arzneimittel. |
| IN163242B (ja) | 1985-05-03 | 1988-08-27 | Hoechst India | |
| AU591196B2 (en) * | 1985-11-15 | 1989-11-30 | Nippon Kayaku Kabushiki Kaisha | Novel forskolin derivatives |
| JPS6310783A (ja) * | 1985-11-15 | 1988-01-18 | Nippon Kayaku Co Ltd | 新規フオルスコリン誘導体 |
| US4740522A (en) * | 1986-08-28 | 1988-04-26 | Hoechst-Roussel Pharmaceuticals Inc. | Oxolabdanes useful as pharmaceuticals for reducing intraocular pressure |
| US5247097A (en) * | 1986-08-28 | 1993-09-21 | Hoechst-Roussel Pharmaceuticals Incorporated | Oxolabdanes |
| US4920146A (en) * | 1986-12-29 | 1990-04-24 | Hoechst Roussel Pharmaceuticals Inc. | Carbamoyloxylabdane compounds useful in reducing intraocular pressure |
| US5646175A (en) * | 1987-12-28 | 1997-07-08 | Hoechst Marion Roussel, Inc. | Carbamoyloxylabdane compounds |
| CA1307530C (en) * | 1986-12-29 | 1992-09-15 | Hoechst-Roussel Pharmaceuticals Inc. | Carbamoyloxylabdanes, intermediates and a process for the preparation thereof and their use as medicaments |
| US5302730A (en) * | 1987-06-29 | 1994-04-12 | Nippon Kayaku Kk | Process for the preparation of 6,7-diacyl-7-deacetylforskolin derivatives |
| JP2504934B2 (ja) * | 1987-06-29 | 1996-06-05 | 日本化薬株式会社 | １，６，７−トリアシルフオルスコリン誘導体 |
| JPH0684367B2 (ja) * | 1987-06-29 | 1994-10-26 | 日本化薬株式会社 | フオルスコリン誘導体の新規製造法 |
| US4902696A (en) * | 1987-10-08 | 1990-02-20 | Hoechst-Roussel Pharmaceuticals, Inc. | Synergistic intraocular pressure lowering combinations |
| US5846992A (en) * | 1987-10-08 | 1998-12-08 | Hoechst Marion Roussel, Inc. | Synergistic intraocular pressure lowering combinations |
| DE3737353A1 (de) * | 1987-11-04 | 1989-05-18 | Hoechst Ag | Neue acyllabdan-derivate, ein verfahren zu ihrer herstellung und ihre verwendung als arzneimittel |
| IN168181B (ja) * | 1987-12-01 | 1991-02-16 | Hoechst India | |
| US4883793A (en) * | 1988-05-09 | 1989-11-28 | Hoechst-Roussel Pharmaceuticals Inc. | Hydrazinocarbonyloxylabdanes for treating cardiac failure |
| US5051132A (en) * | 1989-06-15 | 1991-09-24 | Nippon Kayaku Kabushiki Kaisha | Lyophilized preparation of 6-(3-dimethylaminopropionyl)forskolin |
| US5093336A (en) * | 1989-07-06 | 1992-03-03 | Hoechat-Roussel Pharmaceuticals, Inc. | 6- and 7-deoxyforskolin and derivatives thereof |
| EP0447962A1 (en) * | 1990-03-17 | 1991-09-25 | Hoechst Aktiengesellschaft | Labdanes and process for their preparation |
| IE911192A1 (en) * | 1990-04-12 | 1991-10-23 | Merck & Co Inc | Substituted aromatic sulfonamides as antiglaucoma agents |
| JP3031498B2 (ja) * | 1990-04-12 | 2000-04-10 | メルク エンド カムパニー インコーポレーテッド | 抗緑内障剤としての置換芳香族スルホンアミド類 |
| YU128291A (sh) * | 1990-07-24 | 1994-09-09 | Joechst Aktiengesellschaft | Postpak za dobijanje 6-(3-substituisanih aminopropionil) 7-deacetilforskolinskih derivata |
| KR102048856B1 (ko) * | 2019-09-20 | 2019-11-26 | 주식회사 램프쿡 | 보조뚜껑을 구비하는 조리용기용 뚜껑 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4517200A (en) * | 1982-12-27 | 1985-05-14 | Schering-Plough Corporation | Method for treating allergic reactions with forskolin |
| DE3581725D1 (de) * | 1984-12-14 | 1991-03-14 | Hoechst Roussel Pharma | Aminoacyllabdane, verfahren und zwischenprodukte zu ihrer herstellung und ihre verwendung als arzneimittel. |
| IN163242B (ja) * | 1985-05-03 | 1988-08-27 | Hoechst India |
-
1986
- 1986-02-21 AT AT86102282T patent/ATE62683T1/de active
- 1986-02-21 DE DE8686102282T patent/DE3678736D1/de not_active Expired - Fee Related
- 1986-02-21 EP EP86102282A patent/EP0193132B1/en not_active Expired - Lifetime
- 1986-02-27 PT PT82097A patent/PT82097B/pt not_active IP Right Cessation
- 1986-02-27 FI FI860842A patent/FI860842A/fi not_active Application Discontinuation
- 1986-02-27 HU HU86836A patent/HUT42080A/hu unknown
- 1986-02-27 ES ES552465A patent/ES8705414A1/es not_active Expired
- 1986-02-28 JP JP61042059A patent/JPS61210081A/ja active Pending
- 1986-02-28 ZA ZA861505A patent/ZA861505B/xx unknown
- 1986-02-28 KR KR1019860001410A patent/KR910007967B1/ko not_active IP Right Cessation
- 1986-02-28 NO NO860758A patent/NO860758L/no unknown
- 1986-02-28 GR GR860571A patent/GR860571B/el unknown
- 1986-02-28 PH PH33461A patent/PH23778A/en unknown
- 1986-02-28 DK DK92786A patent/DK92786A/da not_active Application Discontinuation
- 1986-02-28 AU AU54236/86A patent/AU577928B2/en not_active Ceased
- 1986-10-30 ES ES557152A patent/ES8801240A1/es not_active Expired
- 1986-10-30 ES ES557151A patent/ES8707724A1/es not_active Expired
- 1986-10-30 ES ES557153A patent/ES8801241A1/es not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| AU577928B2 (en) | 1988-10-06 |
| JPS61210081A (ja) | 1986-09-18 |
| EP0193132A3 (en) | 1987-07-29 |
| ES8707724A1 (es) | 1987-08-16 |
| KR910007967B1 (ko) | 1991-10-04 |
| DE3678736D1 (de) | 1991-05-23 |
| ES8801241A1 (es) | 1988-01-01 |
| KR860007277A (ko) | 1986-10-10 |
| FI860842A0 (fi) | 1986-02-27 |
| PH23778A (en) | 1989-11-03 |
| FI860842A (fi) | 1986-09-02 |
| ES552465A0 (es) | 1987-05-01 |
| GR860571B (en) | 1986-06-18 |
| ATE62683T1 (de) | 1991-05-15 |
| HUT42080A (en) | 1987-06-29 |
| ES557153A0 (es) | 1988-01-01 |
| ES8801240A1 (es) | 1988-01-01 |
| DK92786D0 (da) | 1986-02-28 |
| ES557152A0 (es) | 1988-01-01 |
| EP0193132A2 (en) | 1986-09-03 |
| NO860758L (ja) | 1986-09-02 |
| ES8705414A1 (es) | 1987-05-01 |
| PT82097A (en) | 1986-03-01 |
| PT82097B (pt) | 1988-07-01 |
| AU5423686A (en) | 1986-09-04 |
| ES557151A0 (es) | 1987-08-16 |
| EP0193132B1 (en) | 1991-04-17 |
| DK92786A (da) | 1986-09-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT82097A (en) | Labdan-derivatives a process for their preparation and their use as medicaments | |
| AR242186A1 (es) | Procedimiento para la produccion de 2,2,6,6,tetra-alquil-4-piperidilaminas. | |
| ZA864298B (en) | Process for the production of 2,2,6,6-tetraalkyl-4-piperidylamines | |
| DE3172006D1 (en) | Novel quinazoline-dione compounds, process for production thereof and pharmaceutical use thereof | |
| ZA879694B (en) | Novel carbamoyloxylabdanes,intermediates and a process for the preparation thereof and their use as medicaments | |
| EP0257631A3 (en) | Oxolabdanes, a process for their preparation and their use as medicaments | |
| EP0268256A3 (en) | 12-halogenated forskolin derivatives, intermediates and a process for the preparation thereof and their use as medicaments | |
| PT83799A (en) | Process for the preparation of novel 2,2:-bi-1h-imidazoles | |
| ZA88409B (en) | 3-methylenespiro/benzofuranpiperidines/,intermediates and a process for the preparation thereof,and their use as medicaments | |
| EP0200132A3 (en) | (aminoalkylthio)hydroxydibenzoxepins, a process for their preparation and their use as medicaments | |
| DE3469358D1 (en) | Novel 3-(4'-aminobutylamino)-propylamino-bleomycin derivatives, a process for their preparation and their use as medicaments | |
| DE3573257D1 (en) | (6,11-dihydro-11-oxodibenz(bm,e)oxepinyl)pentanols, a process and intermediates for their preparation and their use as medicaments |